ELVITEGRAVIR — all Canadian products
4 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ELVITEGRAVIR, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02449498 | GENVOYA | GILEAD SCIENCES CANADA INC | Tablet | Oral | ELVITEGRAVIR 150 MG; COBICISTAT 150 MG; EMTRICITABINE 200 MG; TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) 10 MG | Marketed | |
| 02397137 | STRIBILD | GILEAD SCIENCES CANADA INC | Tablet | Oral | ELVITEGRAVIR 150 MG; COBICISTAT 150 MG; EMTRICITABINE 200 MG; TENOFOVIR DISOPROXIL FUMARATE 300 MG | Marketed | |
| 02411172 | VITEKTA | GILEAD SCIENCES CANADA INC | Tablet | Oral | ELVITEGRAVIR 85 MG | Cancelled Post Market | |
| 02411180 | VITEKTA | GILEAD SCIENCES CANADA INC | Tablet | Oral | ELVITEGRAVIR 150 MG | Cancelled Post Market |
Browse other molecules: